Any person who has signs and symptoms suggestive of TB including a cough for more than 2 weeks, and a fever for more than 2 weeks, significant weight loss, haemoptysis (coughing blood) etc. and any abnormality in a chest radiograph should be evaluated to find out if they have TB.
Children with a persistent fever and/or cough for more than 2 weeks, children who have a loss of weight or no weight gain, and/or children who are household contacts of people who have already been diagnosed as having pulmonary TB must also be evaluated for TB.
People living with HIV (PLHIV), people who are malnourished, who have diabetes or cancer, and people on steroid therapy should be regularly screened for signs and symptoms suggestive of TB.
Enhanced case finding should be undertaken in certain “high risk” populations such as healthcare workers, prisoners & slum dwellers.
Enhanced case finding means having a high level of suspicion for TB in all encounters. Then excluding TB (or indeed identifying TB) using a combination of clinical queries, radiographic and microbiologic testing.
The three tests are sputum smear microscopy, chest X -ray, and the new CB-NAAT test. The CB-NAAT test is now being made available throughout India. The CB-NAAT test is called Genexpert in most countries outside India. The new recommendations are contained in the Revised Technical & Operational Guidelines for TB Control in India. Whether the new recommendations are being followed does depend on how quickly different states are complying with the new strategic plan.
A presumptive pulmonary TB patient, is a patient with any of the signs and symptoms of TB. Most presumptive TB patients should start by having a smear examination and a chest x ray (CXR).
If the smear test is positive then this is referred to as Microbiologically confirmed TB, and the patient should start on TB treatment as soon as possible.
The smear test is not always a very reliable test. So if the smear test is negative, but the chest X ray suggests TB, or a CXR is not available, then the patient should go on to have a CB-NAAT test. A CB-NAAT test should also be carried out if there is clinically a very high level of suspicion that the patient has TB.
People who are HIV positive should have a CB-NAAT test straight away.
The CB-NAAT test is a test for TB, and it also shows if the person has resistance to the drug rifampicin (Rif). There are also now starting to be some alternatives such as the TrueNat test which should be cheaper as it has been developed in India.
If TB bacteria are detected, which means that the person has TB, then the test will also show that the person is either sensitive to Rif, is resistant to Rif, or the result may be unclear.
If the person is sensitive to Rif then this is microbiologically confirmed TB and the person should be started on basic TB treatment as soon as possible.
If the Rif result is not clear, then the CB-NAAT test should be repeated. If the result is still unclear on a second sample, then a fresh sputum sample should be collected in order that different tests such as culture can be carried out.
If the test shows that the person is resistant to Rif then the person should be referred to those people who can recommend the treatment that should be provided for people who are Rif resistant.
If TB bacteria are not detected, then the person has probably not got TB, and an alternative diagnosis should be considered.
PMDT criteria is the Programmatic Management of Drug Resistant TB. As far as diagnostic tests for TB are concerned, if there is a possibility that a person has drug resistant TB, then a CB-NAAT test should be done straight away.
All presumptive TB patients should be offered HIV counseling and testing. However, the diagnosis tests for TB should not be delayed.
Sputum tests are very important in diagnosing TB, so paying attention to the detail of collecting a good sputum sample is very important. A number of studies have looked at this, and the general view is that two samples are almost as good as three samples.
Would you like to send us a comment about this page?
(These are PDFs which may be slow to load & not all may be directly referred to on this page)
Guidelines on Programmatic Management of Drug-resistant Tuberculosis in India (PMDT) PMDT
Guidelines on Programmatic Management of Drug-resistant Tuberculosis in India Annexes (PMDT) PMDTAnnexures
RNTCP National Strategic Plan 2012 – 2017 NSP-2012-2017
RNTCP National Strategic Plan 2017 – 2025 NSP Draft 2017-2025
Standards for TB Care in India Standards TB Care India
TB India 2017 Revised National TB Control Programme Annual Status Report, New Delhi, 2017 TB India 2017
Technical and Operational Guidelines for Tuberculosis Control in India 2016 Part 1 TOG-Part-1
Technical and Operational Guidelines for Tuberculosis Control in India 2016 Part 2 TOG-Part-2